Torna ai risultati
Scheda bibliografica · Consultazione e accesso
Artículo

MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8

Nijhuis, Anke et al · Springer · 2017

Testo completo ad accesso aperto
Lettura rapida. Controlla i dati essenziali della risorsa e accedi al contenuto con il pulsante principale. La scheda mostra solo le informazioni necessarie per identificare, citare e aprire l’opera.

Accesso alla risorsa

Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.

CONICET Digital CONICET Digital OAI-PMH
Entrar por CONICET Digital
Accesso principale

Testo completo ad accesso aperto

Texto completo identificado como acceso abierto.
Apri testo

Riepilogo

Descripción general del contenido del recurso.

The miR-29 family is involved in fibrosis in multiple organs, including the intestine where miR-29b facilitates TGF-β-mediated up-regulation of collagen in mucosal fibroblasts from Crohn’s disease (CD) patients. Myeloid cell leukemia-1 (MCL-1), a member of the B-cell CLL/Lymphoma 2 (BCL-2) apoptosis family, is involved in liver fibrosis and is targeted by miR-29b via its 3’-UTR in cultured cell lines. We investigate the role of MCL-1 and miR-29b in primary intestinal fibroblasts and tissue from stricturing CD patients. Transfection of CD intestinal fibroblasts with pre-miR-29b resulted in a significant increase in the mRNA expression of MCL-1 isoforms [MCL-1Long (L)/Extra Short (ES) and MCL-1Short (S)], although MCL-1S was expressed at significantly lower levels. Western blotting predominantly detected the anti-apoptotic MCL-1L isoform, and immunofluorescence showed that staining was localised in discrete nuclear foci. Transfection with pre-miR-29b or anti-miR-29b resulted in a significant increase or decrease, respectively, in MCL-1L foci. CD fibroblasts treated with IL-6 and IL-8, inflammatory cytokines upstream of MCL-1, increased the total mass of MCL-1L-positive foci. Furthermore, transfection of intestinal fibroblasts with pre-miR-29b resulted in an increase in mRNA and protein levels of IL-6 and IL-8. Finally, immunohistochemistry showed reduced MCL-1 protein expression in fibrotic CD samples compared to non-stricturing controls. Together, our findings suggest that induction of MCL-1 by IL-6/IL-8 may surmount any direct down-regulation by miR-29b via its 3’-UTR. We propose that an anti-fibrotic miR-29b/IL-6 IL-8/MCL-1L axis may influence intestinal fibrosis in CD. In the future, therapeutic modulation of this pathway might contribute to the management of fibrosis in CD. Fil: Nijhuis, Anke. Queen Mary University of London; Reino Unido Fil: Curciarello, Renata. Queen Mary University of London; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina

Come citare

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Nijhuis, A. E. A. (2017). MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8. http://hdl.handle.net/11336/57423

MLA

Nijhuis, Anke et al. "MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8." 2017. http://hdl.handle.net/11336/57423.

Chicago

Nijhuis, Anke et al. 2017. "MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8.". http://hdl.handle.net/11336/57423.

Harvard

Nijhuis, A. E. A. 2017, MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8, Springer, available at: http://hdl.handle.net/11336/57423 [Accessed 7 Aug. 2026].

Condividi e stampa

Salva la scheda, copia il link permanente o stampala in PDF.

Esporta riferimento

Esporta il record nei formati più comuni per usarlo con un gestore bibliografico.

Dettagli della risorsa

Informazioni bibliografiche utili per verificare che sia il materiale corretto.

Titolo
MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8
Autore / collaboratori
Nijhuis, Anke et al
Editore
Springer
Anno di pubblicazione
2017
ISSN
0302-766X
ISSN
0302-766X
Lingua
Inglés

Soggetti

Esplora risorse correlate a partire da questi soggetti.

Copiato